Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM1315MO2
TNBC
Basal B
JNK-IN-5A
JNK
JNK
10875.144
uM
0.71710
0.89002
-0.7907 -0.7631 4.2897 0.6952
0.9934
0.7785
SUM1315MO2
TNBC
Basal B
L-779450
BRAF
MAPK
10875.149
uM
21.03160
29.56310
-0.1898 -1.0000 3.2264 0.1565
0.7999
0.7469
SUM1315MO2
TNBC
Basal B
L-779450
BRAF
MAPK
12428.166
uM
19.14470
54.07310
0.2378 -1.0000 1.0581 0.0827
0.9279
0.8223
SUM1315MO2
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
9044.098
uM
14.0530
113.88450
0.4184 -1.0000 0.5251 0.1110
0.8304
0.8807
SUM1315MO2
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7528.098
uM
inf
0.18408
0.7450 0.7547 1.4124 0.0787
0.9255
0.9717
SUM1315MO2
TNBC
Basal B
LBH589
HDAC
HDAC
12428.167
uM
0.30244
0.74256
-0.8743 -0.9050 1.1503 0.5677
0.9960
1.0169
SUM1315MO2
TNBC
Basal B
LBH589
HDAC
HDAC
10875.154
uM
0.18989
0.30284
-0.9937 -0.9660 2.3047 0.6828
0.9972
0.7163
SUM1315MO2
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12428.167
uM
0.05317
0.41497
-0.9765 -1.0000 0.5347 0.7021
0.9708
1.0169
SUM1315MO2
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10875.154
uM
0.03307
0.09533
-0.9963 -0.8668 0.9498 0.8165
0.9882
0.7163
SUM1315MO2
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7528.084
uM
inf
inf
0.8853 0.8853 0.0000 0.0300
0.4220
1.0247
SUM1315MO2
TNBC
Basal B
Methotrexate
DHFR
Metabolism
9044.084
uM
inf
inf
0.8434 0.8434 0.0000 -0.0323
0.5296
0.4769
SUM1315MO2
TNBC
Basal B
Methylglyoxal
13197.184
uM
477.56670
843.97530
-0.9998 -0.9846 1.9113 0.6795
0.9941
0.5530
SUM1315MO2
TNBC
Basal B
Methylglyoxal
13520.184
uM
567.6950
786.82260
-0.9992 -0.9966 3.3588 0.6425
0.9974
0.6738
SUM1315MO2
TNBC
Basal B
MG-132
Proteasome
Proteasome
14281.189
uM
inf
inf
-0.9999 -0.9999 0.0000 0.8447
0.5712
0.4986
SUM1315MO2
TNBC
Basal B
MG-132
Proteasome
Proteasome
14281.189
uM
inf
inf
-0.9999 -0.9999 0.0000 0.8447
0.5712
0.4986
SUM1315MO2
TNBC
Basal B
MG-132
Proteasome
Proteasome
10875.145
uM
0.10386
0.19799
-0.9918 -0.9954 1.6979 0.8831
0.9985
0.7643
SUM1315MO2
TNBC
Basal B
MG-132
Proteasome
Proteasome
10875.145
uM
0.10386
0.19799
-0.9918 -0.9954 1.6979 0.8831
0.9985
0.7643
SUM1315MO2
TNBC
Basal B
MG-132
Proteasome
Proteasome
12428.17
uM
0.12477
0.22218
-0.9639 -0.9614 1.8587 0.8733
0.9993
0.9724
SUM1315MO2
TNBC
Basal B
MG-132
Proteasome
Proteasome
12428.17
uM
0.12477
0.22218
-0.9639 -0.9614 1.8587 0.8733
0.9993
0.9724
SUM1315MO2
TNBC
Basal B
Pevonedistat
NAE1
NAE1
10875.148
uM
inf
inf
0.9445 0.9445 0.0000 0.2592
0.0755
0.7605
SUM1315MO2
TNBC
Basal B
Pevonedistat
NAE1
NAE1
12428.135
uM
0.06237
0.1150
-0.3745 -0.3343 0.8368 0.6468
0.9917
0.8862
SUM1315MO2
TNBC
Basal B
Nilotinib
ABL
nRTK
10875.145
uM
inf
inf
1.0500 1.0500 0.0000 -0.0427
-3.3446
0.7643
SUM1315MO2
TNBC
Basal B
Nilotinib
ABL
nRTK
12428.17
uM
inf
inf
1.0500 1.0500 0.0000 -0.0450
-2.6385
0.9724
SUM1315MO2
TNBC
Basal B
NSC 663284
CDC25
CDC
10875.152
uM
0.93379
1.83720
-0.9966 -1.0000 1.6234 0.7461
0.9886
0.7465
SUM1315MO2
TNBC
Basal B
NSC 663284
CDC25
CDC
12428.152
uM
1.13290
1.65830
-0.9802 -0.9909 2.8676 0.7650
0.9912
0.8719